Showing results (331-340 of 1,271) with videos related to
Sort By:
Pageof 128
Psychopharmacology Bulletin|January 1, 1996
An open study of buspirone augmentation of serotonin-reuptake inhibitors in body dysmorphic disorderK A PhillipsPsychopharmacology Bulletin|January 1, 1996
Sertraline in the treatment of premenstrual dysphoric disorderK A Yonkers, U Halbreich, E Freeman, et al.Psychopharmacology Bulletin|January 1, 1996
Lithium treatment of bipolar affective disorders under naturalistic followup conditionsJ F Goldberg, M Harrow, A C LeonPsychopharmacology Bulletin|January 1, 1996
Differences in thyroid function studies in acutely manic adolescents with and without attention deficity hyperactivity disorder (ADHD)S A West, K W Sax, S P Stanton, et al.Psychopharmacology Bulletin|January 1, 1996
Effect of varying haloperidol plasma levels on negative symptoms in schizophrenia and schizoaffective disorderJ Volavka, T B Cooper, P Czobor, et al.Psychopharmacology Bulletin|January 1, 1996
A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trialM Petit, J Raniwalla, J Tweed, et al.Psychopharmacology Bulletin|January 1, 1996
Obsessive-compulsive symptoms in schizophrenia: a comparison of olanzapine and placeboR W Baker, D Ames, D S Umbricht, et al.Psychopharmacology Bulletin|January 1, 1996
Regional cerebral blood flow changes associated with risperidone treatment in elderly schizophrenia patients: a pilot studyI Berman, A Merson, C Sison, et al.Psychopharmacology Bulletin|January 1, 1996
Lithium and neuroleptics in combination: the spectrum of neurotoxicity [corrected]S A GoldmanPsychopharmacology Bulletin|January 1, 1996
Selegiline in adults with attention deficit hyperactivity disorder: clinical efficacy and safetyM Ernst, L L Liebenauer, P H Jons, et al.Pageof 128